טוען...
Has the New USP Assay for Heparin Affected Dosage for Patients Undergoing Cardiopulmonary Bypass?
In October 2009, the U.S. Pharmacopoeia (USP) changed the monograph for heparin to bring USP units in line with international units for heparin. The result was a 10% decrease in potency as measured by in vitro laboratory tests. This decrease led to questions regarding dosing guidelines. There existe...
שמור ב:
| הוצא לאור ב: | J Extra Corpor Technol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of ExtraCorporeal Technology
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4557576/ https://ncbi.nlm.nih.gov/pubmed/23930380 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|